Prior Treatment Time Affects Survival Outcomes in Metastatic Breast Cancer

PURPOSE: Sequential drug treatments in metastatic breast cancer (MBC) are disparate. Clinical trial data includes limited reporting of treatment context, primarily including the number of prior therapies. This study evaluates the relationship between prior treatment time, prior lines of treatment, a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JCO Clin Cancer Inform
Huvudupphovsmän: Rocque, Gabrielle B., Gilbert, Aidan, Williams, Courtney P., Kenzik, Kelly M., Nakhmani, Arie, Kandhare, Pravinkumar G., Bhatia, Smita, Burkard, Mark E., Azuero, Andres
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Clinical Oncology 2020
Ämnen:
Original Reports
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444642/
https://ncbi.nlm.nih.gov/pubmed/32479187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/CCI.20.00008
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk